Last edition
News about "obstructive hypertrophic cardiomyopathy treatment"
US FDA Approves First Drug for Rare Pediatric Heart Condition
The US FDA has approved first drug to improve functional capacity and symptoms in children with rare inherited heart condition.
Obstructive Hypertrophic Cardiomyopathy Treatment | 03/10/2026 | By News Bureau
Bristol Myers Squibb Reports Positive Phase 3 SCOUT-HCM Trial Results
Bristol Myers Squibb reports positive Phase 3 SCOUT-HCM results showing Camzyos efficacy and safety in adolescents with oHCM, achieving significant LVOT reduction with no new safety concerns.
Obstructive Hypertrophic Cardiomyopathy Treatment | 30/03/2026 | By News Bureau | 246
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy